This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
WOW! That's great news! They said previously that they only considered one of those 5 (which would have been strange) but now all 5 are approved. I hope they find a strategy to move forward with the rest of residual function splice mutations, there are so many different ones. It seems that they didn't use in vitro testing to approve these and I have not seen any published results of in vitro testing of potentiator efficacy on splicing mutations so I wonder if in vitro results are actually unreliable when it comes to splicing defects?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.